Medically reviewed by Dr. Rajesh Harripersad, LPC-S, LCDC — U.S. Army Retired; EMDR Certified Behavioral Healthcare Provider. Regional Director, Virtue Recovery and Ambience Recovery Center.
What Kratom Is — and Why People Use It
Kratom is the leaf of Mitragyna speciosa, a Southeast Asian tree, sold in the U.S. as powder, capsules, extracts, shots, and gummies. People take it for reasons that deserve respect rather than judgment: chronic pain, energy, anxiety — and very often, to self-treat opioid withdrawal after deciding to get off painkillers or heroin without help. Roughly 1.7 million Americans used kratom in a year by federal survey count, and the true number is likely higher.
Its chemistry explains both the appeal and the trap: kratom's active alkaloids — mitragynine and 7-hydroxymitragynine (7-OH) — act on the same mu-opioid receptors as morphine and oxycodone. At low doses kratom feels stimulating; at higher doses, sedating and opioid-like. The FDA has never approved it for any use and warns of liver toxicity, seizures, and substance use disorder; legally, it isn't a drug, supplement, or food additive — it exists in a gap.
None of that means everyone who uses kratom is addicted. It means kratom is an opioid-receptor drug in a gas-station wrapper — and with regular heavy use, it behaves like one.
The 7-OH Problem: When 'Kratom' Isn't Kratom Anymore
This is the most important development in years, and almost nobody outside federal agencies is talking about it. In natural kratom leaf, 7-OH is a trace alkaloid — under 2% of the total. But a new generation of concentrated products — '7-OH' tablets, shots, and gummies sold in smoke shops — isolates and boosts it. FDA's scientific assessment found 7-OH suppresses breathing with more than three times morphine's potency; the DEA says its abuse potential resembles Schedule I and II opioids like heroin and fentanyl.
The federal response is moving fast: in July 2026 the DEA formally proposed placing concentrated 7-OH products into Schedule I — a proposal, not yet final, that explicitly does not target natural leaf kratom. Texas is named in the federal record among states whose health authorities linked 7-OH products to overdose cases in 2025. The practical takeaway for anyone using these products: a '7-OH shot' is not an herbal supplement; it is a potent opioid in a bright wrapper, and dependence on it looks like opioid dependence — because that's what it is.
Kratom leaf vs. extracts vs. 7-OH products
| Traditional leaf/powder | Kratom extracts | Concentrated 7-OH products | |
|---|---|---|---|
| What it is | Ground Mitragyna speciosa leaf | Concentrated alkaloids from leaf | Isolated or synthetic 7-OH in tablets, shots, gummies |
| 7-OH content | Trace — under 2% of alkaloids | Elevated and variable | Deliberately boosted — the product IS 7-OH |
| Effect profile | Mild stimulant to opioid-like by dose | Stronger, less predictable | Potent opioid effects; breathing suppression >3× morphine potency |
| Regulatory status | Legal in Texas (18+, Chapter 444) | Legal if within Texas's 7-OH cap | Proposed federal Schedule I (July 2026); many already violate Texas law |
Is Kratom Addictive? What the Record Surge Shows
The honest answer: with regular, heavy use — and especially with extracts and 7-OH products — yes. Kratom dependence is real, produces genuine opioid-type withdrawal, and is showing up in the national data at record levels. U.S. poison centers logged 3,434 kratom exposure reports in 2025 — the highest ever recorded, roughly thirteen times the 2015 count — with the CDC attributing the spike to high-potency semisynthetic formulations. Adults 40–59 are the fastest-growing group.
The same data carry a second, critical message: kratom's worst outcomes are overwhelmingly polysubstance events. Of 233 kratom-associated deaths across the decade, 79% involved other substances — opioids in 62% of fatal cases, benzodiazepines and stimulants in a fifth each. Kratom plus other depressants is where the real danger concentrates, and it's why an honest assessment asks about everything, not just the powder.
Kratom reports to U.S. poison centers
The 2025 record coincides with the spread of concentrated 7-OH products. National Poison Data System reports.
Signs of Kratom Dependence
What it looks like when the 'natural supplement' has become a need:
- Dosing has climbed — from a teaspoon to many grams, or from powder to extracts to 7-OH shots
- Flu-like sickness — aches, runny nose, chills, nausea — whenever too many hours pass between doses
- Spending serious money at smoke shops; buying in bulk out of fear of running out
- Using kratom to get through work, sleep, or social situations rather than by choice
- Failed attempts to quit or taper that ended in misery by day two
- Irritability, anxiety, and low mood that lift only after dosing
- Hiding the extent of use from family — often easier because 'it's legal and natural'
Kratom Withdrawal: Opioid Withdrawal's Quieter Sibling
Because kratom works on opioid receptors, its withdrawal is opioid withdrawal in character: muscle aches, runny nose, chills and sweats, nausea and diarrhea, insomnia, anxiety, irritability, and strong cravings. With traditional leaf use it often runs milder than heroin or fentanyl withdrawal; with heavy extract or 7-OH use, it can be every bit as fierce — because pharmacologically, those products are potent opioids.
Withdrawal typically begins 12–24 hours after the last dose, peaks over days one to three, eases through the first week, and resolves over two to four weeks — with mood and sleep sometimes lagging longer. It is rarely dangerous by itself, but it is exactly miserable enough to defeat unsupported quitting, which is why so many people cycle for years through a product they bought precisely because they thought it would be easy to stop.
The kratom withdrawal timeline
Heavier use — especially extracts and 7-OH products — runs harder and longer. Medical detox flattens the whole curve.
12–24 hours
Onset
Restlessness, anxiety, muscle discomfort, and cravings begin as the last dose wears off.
Days 1–3
Peak
The hardest stretch: body aches, GI distress, chills and sweats, insomnia, and low mood.
Days 4–7
Sub-acute
Physical symptoms subside; sleep starts normalizing; psychological symptoms persist.
Weeks 2–4
Resolution
Most symptoms resolve. Cravings arrive in waves tied to routine and stress.
Beyond (some people)
The long tail
Mood, energy, and sleep can lag for weeks after heavy use — addressed in ongoing care, not endured alone.
Source: Clinical consensus (poison-center and case literature)
How Kratom Addiction Is Treated — Including the Medication Question
Because kratom dependence is opioid-receptor dependence, treatment draws on the opioid playbook. Medically supervised detox manages the withdrawal week with comfort medications and monitoring. And there's an evidence-based medication conversation most kratom pages skip entirely: published case literature and an active NIH-registered clinical trial support buprenorphine (Suboxone) and clonidine for managing kratom withdrawal and dependence — the same tools that transformed opioid treatment. Whether medication belongs in your plan is a clinical decision; the point is that real options exist.
From detox, care steps into our continuum — residential treatment, PHP day treatment, or intensive outpatient — with cognitive behavioral therapy, and honest work on whatever the kratom was doing: chronic pain that needs real management, anxiety that deserves first-line treatment, energy and mood that were being rented from a receptor.
If You Started Kratom to Get Off Opioids — Read This
This is the most common kratom story we hear, and it deserves to be said without a trace of shame: you tried to solve an opioid problem on your own, with something legal, cheap, and sold down the street. That took real intent. It also, for many people, swapped one opioid-receptor dependence for another — quieter, slower, but running on the same brain circuitry. Finding yourself dependent on kratom does not mean you're 'back to square one.' It means the self-treatment plan needs an upgrade to an actual treatment plan.
The upgrade is concrete: proper assessment of where your opioid physiology actually is, medication options with real evidence behind them, and structured support for the pain, anxiety, or history that started the chain. People who come to us through the kratom door routinely do exceptionally well — the motivation that drove the self-treatment attempt is the same motivation that drives recovery, finally pointed at tools that work.
Is Kratom Legal in Texas? The Exact Answer
Yes — with specifics that matter. Under the Texas Kratom Consumer Health and Safety Protection Act (Chapter 444, Health & Safety Code, effective September 2023), kratom is legal for adults; selling to anyone under 18 is a misdemeanor. Texas regulates kratom as a food, requires labeling with serving directions, and — here's the part nobody quotes — prohibits products whose 7-OH exceeds 2% of the alkaloid content, and bans synthetic alkaloids including synthetic 7-OH outright.
Read that against the shelf at a Killeen smoke shop: many concentrated '7-OH' tablets and shots sold in Texas appear, on their face, to be products Chapter 444 already forbids — enforced by civil penalties starting at $250. Meanwhile the DEA's proposed federal scheduling of concentrated 7-OH is pending but not final, and a 2025 state bill to tighten Texas's kratom law passed the Senate and died in the House. Legal-to-buy has never meant safe — and in the case of 7-OH products, it doesn't even reliably mean legal.
Kratom Treatment in Central Texas
Ambience Recovery Center treats adults across Central Texas — Killeen, Harker Heights, Temple, Belton, Copperas Cove, Waco, and the Austin corridor, including the Fort Cavazos military community, where kratom's smoke-shop availability and 'natural' marketing have made it a quiet fixture. Because kratom doesn't appear on standard drug panels, dependence often runs deep before anyone notices.
If the powder, the extract, or the little red shot bottle has become non-negotiable, that's the signal. One confidential call gets you an honest assessment — including the medication conversation — and free insurance verification, TRICARE questions included, before you decide anything.
Sources & Medical References
- CDC MMWR — Increases in Kratom-Related Reports to Poison Centers, United States, 2015–2025 (March 2026)
- FDA — FDA and Kratom
- FDA — Hiding in Plain Sight: 7-OH Products
- DEA — Notice of Intent: Temporary placement of 7-hydroxymitragynine above a specified concentration in Schedule I (Federal Register, July 2026)
- Texas SB 497 (2023) — Texas Kratom Consumer Health and Safety Protection Act (H&S Code Ch. 444)
- NIDA — Kratom research topic
- ClinicalTrials.gov — Kratom Use Disorder Management Using Clonidine and/or Buprenorphine (NCT05883358)
- Comstock G, et al. State-level kratom regulations and poison center-reported outcomes. Addiction, 2026




